1. 193 DECREASED EXPRESSION OF CYTOTOXIC T-CELL ACTIVATION GENES IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS WITH CROHN'S DISEASE. (1st January 2004) Authors: Kim, Hui Jin; Lentz, Jennifer J; Sornasse, Thierry; Mannick, Elizabeth E Journal: Journal of investigative medicine Issue: Volume 52(2004)Supplement 1 Page Start: S291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 195 PREVALENCE OF A SINGLE NUCLEOTIDE POLYMORPHISM IN FLJ21425 IN LOUISIANA PATIENTS WITH CROHN'S DISEASE. (1st January 2004) Authors: Zapata-Velandia, Adriana M.; Ng, San-San; Brennan, Rebecca; Gastanaduy, Mariela M; Byrne, Patrick; Lentz, Jennifer J; Udall, John N; Brown, Raynorda; Schmidt-Sommerfeld, Eberhard; Sornasse, Thierry; Keats, Bronya J; Mannick, Elizabeth E Journal: Journal of investigative medicine Issue: Volume 52(2004)Supplement 1 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. (20th October 2021) Authors: McInnes, Iain B; Szekanecz, Zoltán; McGonagle, Dennis; Maksymowych, Walter P; Pfeil, Alexander; Lippe, Ralph; Song, In-Ho; Lertratanakul, Apinya; Sornasse, Thierry; Biljan, Ana; Deodhar, Atul Journal: Rheumatology Issue: Volume 61:Number 5(2022) Page Start: 1783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0272 EVALUATION OF CXCL13, SICAM-1, MMP-3 AND S100A8/A9 AS SERUM BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB. (June 2019) Authors: James Haddon, D.; Sornasse, Thierry; Townsend, Michael J.; Pei, Jinglan; Michalska, Margaret Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S808 Mechanisms of Non-Response to Adalimumab on Inflammatory Bowel Disease: Peripheral Proteomic and Transcriptomic Profiling from the SERENE-CD and SERENE-UC Studies. (October 2021) Authors: Panés, Julian; Verstockt, Bram; Pivorunas, Valerie; Butler, James; Mahi, Naim; Ruzek, Melanie; Sornasse, Thierry; Fann, James; Hong, Feng; Cao, Xiaohong; Smaoui, Nizar; Davis, Justin Wade; Kalabic, Jasmina; Song, Alexandra; Guay, Heath; Salas, Azucena; Kennedy, Nick; Ahmad, Tariq; Vermeire, Severine Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Issue 10038 (25th June 2016) Authors: Khanna, Dinesh; Denton, Christopher P; Jahreis, Angelika; van Laar, Jacob M; Frech, Tracy M; Anderson, Marina E; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Pope, Janet E; Riemekasten, Gabriela; Steen, Virginia; Müller-Ladner, Ulf; Lafyatis, ... Journal: Lancet Issue: Volume 387:Issue 10038(2016) Page Start: 2630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®. Issue 7 (2nd October 2016) Authors: Ganguly, Bishu; Balasa, Balaji; Efros, Lyubov; Hinton, Paul R.; Hartman, Stephen; Thakur, Archana; Xiong, Joanna M.; Schmidt, Brian; Robinson, Randy R.; Sornasse, Thierry; Vexler, Vladimir; Sheridan, James P. Journal: MAbs Issue: Volume 8:Issue 7(2016) Page Start: 1417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. Issue 9 (31st May 2018) Authors: Denton, Christopher P; Ong, Voon H; Xu, Shiwen; Chen-Harris, Haiyin; Modrusan, Zora; Lafyatis, Robert; Khanna, Dinesh; Jahreis, Angelika; Siegel, Jeffrey; Sornasse, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 9(2018) Page Start: 1362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0166 TREATMENT WITH UPADACITINIB IS ASSOCIATED WITH IMPROVEMENTS IN REVERSE CHOLESTEROL TRANSPORT IN PATIENTS WITH RHEUMATOID ARTHRITIS: CORRELATION WITH CHANGES IN INFLAMMATION AND HDL LEVELS. (June 2019) Authors: Charles-Schoeman, Christina; Sornasse, Thierry; Sokolove, Jeremy Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0181 TREATMENT WITH UPADACITINIB RESULTS IN THE NORMALIZATION OF KEY PATHOBIOLOGIC PATHWAYS IN PATIENTS WITH RHEUMATOID ARTHRITIS: BIOMARKER RESULTS FROM THE PHASE 3 SELECT-NEXT AND SELECT-BEYOND STUDIES. (June 2019) Authors: Sornasse, Thierry; Sokolove, Jeremy; McInnes, Iain Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗